UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CD137 (4-1BB) stimulation leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity

Leukemia, 2021-12, Vol.35 (12), p.3482-3496

2021

Volltextzugriff (PDF)

Serum-free production and purification of chimeric IgA antibodies

Journal of immunological methods, 2009-07, Vol.346 (1), p.26-37

2009

Volltextzugriff (PDF)

The Fc-engineered CD19 antibody MOR208 (XmAb5574) induces natural killer cell-mediated lysis of acute lymphoblastic leukemia cells from pediatric and adult patients

Leukemia, 2013-07, Vol.27 (7), p.1595-1598

2013

Volltextzugriff (PDF)

CD20‐Specific Immunoligands Engaging NKG2D Enhance γδ T Cell‐Mediated Lysis of Lymphoma Cells

Scandinavian journal of immunology, 2017-10, Vol.86 (4), p.196-206

2017

Volltextzugriff (PDF)

The novel tribody [(CD20)2xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells

Leukemia, 2013-01, Vol.27 (1), p.190-201

2013

Volltextzugriff (PDF)

Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity

Leukemia, 2012-04, Vol.26 (4), p.830-834

2012

Volltextzugriff (PDF)

Bispecific antibodies targeting cancer cells

Biochemical Society transactions, 2002-08, Vol.30 (4), p.507-511

2002

Volltextzugriff (PDF)

The novel immunotoxin HM1.24-ETA′ induces apoptosis in multiple myeloma cells

Blood cancer journal (New York), 2014-06, Vol.4 (6), p.e219-e219

2014

Volltextzugriff (PDF)

A novel human Fc-optimized ICAM-1/CD54 antibody (MSH-TP15e) with potent anti-myeloma activity in vitro and in vivo

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e221-e221

2015

Volltextzugriff (PDF)

062 Phage display-based isolation of collagen VII-specific monoclonal antibodies from mice with actively induced Epidermolysis Bullosa Acquisita

Journal of investigative dermatology, 2022-12, Vol.142 (12), p.S191-S191

2022

Volltextzugriff (PDF)

Human kappa light chain targeted Pseudomonas exotoxin A — identifying human antibodies and Fab fragments with favorable characteristics for antibody–drug conjugate development

Journal of immunological methods, 2011-08, Vol.371 (1-2), p.122-133

2011

Volltextzugriff (PDF)

A CD19-specific single-chain immunotoxin mediates potent apoptosis of B-lineage leukemic cells

Leukemia, 2007-07, Vol.21 (7), p.1405-1412

2007

Volltextzugriff (PDF)

Enhancing Cytokine-Induced Killer (CIK) cell activity with Her2-specific Fc-engineered antibodies and antibody derivatives

European journal of cancer (1990), 2018-03, Vol.92, p.S23-S24

2018

Volltextzugriff (PDF)

P10.19.B An immunotoxin targeting CD317 for the treatment of glioblastoma

Neuro-oncology (Charlottesville, Va.), 2022-09, Vol.24 (Supplement_2), p.ii53-ii53

2022

Volltextzugriff (PDF)

T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice

Cell, 2008-08, Vol.134 (4), p.577-586

2008

Volltextzugriff (PDF)

PL03.3.A Development and characterization of CD317-specific CAR T cells as an innovative immunotherapeutic strategy against glioblastoma

Neuro-oncology (Charlottesville, Va.), 2021-09, Vol.23 (Supplement_2), p.ii2-ii2

2021

Volltextzugriff (PDF)

Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor

Biochemical and biophysical research communications, 2004-07, Vol.319 (4), p.1216-1221

2004

Volltextzugriff (PDF)

Effector mechanisms of therapeutic antibodies against ErbB receptors

Current opinion in immunology, 2008-08, Vol.20 (4), p.436-443

2008

Volltextzugriff (PDF)

Hematopoietic Stem/Progenitor Cells and Engineering: FROM HARMFUL TO USEFUL: EXPLOITING A LEUKEMIC TRANSCRIPTION FACTOR FOR LARGE-SCALE EX VIVO MANUFACTURE OF HUMAN MACROPHAGES

Cytotherapy (Oxford, England), 2022-05, Vol.24 (5), p.S100-S101

2022

Volltextzugriff (PDF)

P08.01 Combined approach of adoptive cell therapy with cytokine-induced killer cells retargeted with immunotools against HER-2-expressing breast cancer

Journal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A25-A26

2022

Volltextzugriff (PDF)

A novel CD19-directed recombinant bispecific antibody derivative with enhanced immune effector functions for human leukemic cells

Journal of immunotherapy, 2008-11, Vol.31 (9), p.871-884

2008

Volltextzugriff (PDF)

CD20-Specific Immunoligands Engaging NKG2D Enhance [gamma][delta] T Cell-Mediated Lysis of Lymphoma Cells

Scandinavian journal of immunology, 2017-10, Vol.86 (4), p.196

2017

Volltextzugriff (PDF)

Optimization of complement recruitment in EGFR-directed antibody therapy

Molecular immunology, 2013-12, Vol.56 (3), p.267-267

2013

Volltextzugriff (PDF)

Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7

Cancer research (Chicago, Ill.), 2005-04, Vol.65 (8), p.3380-3388

2005

Volltextzugriff (PDF)

Effective lysis of lymphoma cells with a stabilised bispecific single‐chain Fv antibody against CD19 and FcγRIII (CD16)

British journal of haematology, 2005-07, Vol.130 (2), p.218-228

2005

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Englisch
(85)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(50)
Humans
(38)
Animals
(29)
Hematology
(21)
Mice
(21)
Oncology
(18)
Biological And Medical Sciences
(16)
Immunotherapy
(15)
Female
(14)
Antibodies
(13)
Immunology
(13)
Medical Sciences
(11)
Hematologic And Hematopoietic Diseases
(10)
Mice, Scid
(10)
Cell Line, Tumor
(9)
Cytotoxicity
(9)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(9)
Lymphoma
(9)
Tumor Cells, Cultured
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

CD137 (4-1BB) stimulation leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity

Serum-free production and purification of chimeric IgA antibodies

The Fc-engineered CD19 antibody MOR208 (XmAb5574) induces natural killer cell-mediated lysis of acute lymphoblastic leukemia cells from pediatric and adult patients

CD20‐Specific Immunoligands Engaging NKG2D Enhance γδ T Cell‐Mediated Lysis of Lymphoma Cells

The novel tribody [(CD20)2xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells

Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity

Bispecific antibodies targeting cancer cells

The novel immunotoxin HM1.24-ETA′ induces apoptosis in multiple myeloma cells

A novel human Fc-optimized ICAM-1/CD54 antibody (MSH-TP15e) with potent anti-myeloma activity in vitro and in vivo

062 Phage display-based isolation of collagen VII-specific monoclonal antibodies from mice with actively induced Epidermolysis Bullosa Acquisita

Human kappa light chain targeted Pseudomonas exotoxin A — identifying human antibodies and Fab fragments with favorable characteristics for antibody–drug conjugate development

A CD19-specific single-chain immunotoxin mediates potent apoptosis of B-lineage leukemic cells

Enhancing Cytokine-Induced Killer (CIK) cell activity with Her2-specific Fc-engineered antibodies and antibody derivatives

P10.19.B An immunotoxin targeting CD317 for the treatment of glioblastoma

T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice

PL03.3.A Development and characterization of CD317-specific CAR T cells as an innovative immunotherapeutic strategy against glioblastoma

Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor

Effector mechanisms of therapeutic antibodies against ErbB receptors

Hematopoietic Stem/Progenitor Cells and Engineering: FROM HARMFUL TO USEFUL: EXPLOITING A LEUKEMIC TRANSCRIPTION FACTOR FOR LARGE-SCALE EX VIVO MANUFACTURE OF HUMAN MACROPHAGES

P08.01 Combined approach of adoptive cell therapy with cytokine-induced killer cells retargeted with immunotools against HER-2-expressing breast cancer

A novel CD19-directed recombinant bispecific antibody derivative with enhanced immune effector functions for human leukemic cells

CD20-Specific Immunoligands Engaging NKG2D Enhance [gamma][delta] T Cell-Mediated Lysis of Lymphoma Cells

Optimization of complement recruitment in EGFR-directed antibody therapy

Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7

Effective lysis of lymphoma cells with a stabilised bispecific single‐chain Fv antibody against CD19 and FcγRIII (CD16)

Suchergebnisse filtern